Quest Diagnostics Incorporated logo
DGXQuest Diagnostics Incorporated

Interest Coverage Ratio: 6.33x

Is the interest coverage ratio high or low?

The interest coverage ratio of 6.33x is 28% below its 5-year average of 8.84x, near the low end of its 5-year range (3.75x–17.37x).

As of Friday, June 26, 2026. 9.51% above its 12-month average of 5.78x.

Interest Coverage

DGX Interest Coverage Ratio

6.33x

Reported quarterly interest coverage; no daily interpolation.

-54.85% 5Y
DGX Interest Coverage Ratio

DGX Average Interest Coverage Ratio Chart

DGX Interest Coverage Ratio

DGX Current vs Average Interest Coverage Ratio Chart

DGX Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

6.33x

INTEREST COVERAGE RATIO AVG TTM

5.78x

INTEREST COVERAGE RATIO AVG 3Y

6.51x

INTEREST COVERAGE RATIO AVG 5Y

8.84x

INTEREST COVERAGE RATIO AVG 10Y

7.06x

INTEREST COVERAGE RATIO AVG 15Y

6.84x

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+9.51%

CURRENT VS 3Y AVG

-2.69%

CURRENT VS 5Y AVG

-28.37%

CURRENT VS 10Y AVG

-10.25%

CURRENT VS 15Y AVG

-7.39%

CURRENT VS 20Y AVG

N/A

DGX Competitors' Interest Coverage Ratio

NAMEMARKET CAPINTEREST COVERAGE RATIOTTM3Y5Y
Quest Diagnostics Incorporated (DGX)$22.83B6.33x5.78x6.51x8.84x
BioNTech SE (BNTX)vs ›$22.76B-45.74x444.02x1201.03x1201.03x
United Therapeutics Corporation (UTHR)vs ›$23.07B77.81x54.95x40.03x35.88x
Moderna, Inc. (MRNA)vs ›$23.71B-307.40x531.75x531.75x531.75x
Labcorp Holdings Inc. (LH)vs ›$21.83B6.77x5.99x5.91x8.30x
Incyte Corporation (INCY)vs ›$21.48B553.04x298.73x269.07x276.66x
Waters Corporation (WAT)vs ›$24.57B12.84x11.03x12.05x13.28x
Mettler-Toledo International Inc. (MTD)vs ›$25.13B16.32x15.71x16.43x18.17x
STERIS plc (STE)vs ›$20.52B18.15x14.10x10.28x10.20x
Veeva Systems Inc. (VEEV)vs ›$25.68BN/AN/AN/AN/A

Financial Health Indicators

Interest Coverage

6.3x

Debt/Equity

0.96

Current Ratio

1.04

Formula: Interest Coverage = EBIT / Interest Expense

Reference ranges:

  • < 1.5x: EBIT is less than 1.5 times interest expense
  • 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
  • 3x - 5x: EBIT is between 3 and 5 times interest expense
  • > 5x: EBIT is more than 5 times interest expense

Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.

Interest Coverage Ratio Formula & Definition

Interest Coverage = EBIT / Interest Expense

The interest coverage ratio measures operating earnings relative to interest expense.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Quest Diagnostics Incorporated (DGX)?
The interest coverage ratio for DGX stock is 6.33x.
Is Quest Diagnostics Incorporated's interest coverage ratio high or low?
The interest coverage ratio of 6.33x is 28% below its 5-year average of 8.84x, near the low end of its 5-year range (3.75x–17.37x).
What is the TTM average interest coverage ratio for Quest Diagnostics Incorporated (DGX)?
The TTM average interest coverage ratio for DGX stock is 5.78x.
What is the 3Y average interest coverage ratio for Quest Diagnostics Incorporated (DGX)?
The 3Y average interest coverage ratio for DGX stock is 6.51x.
What is the 5Y average interest coverage ratio for Quest Diagnostics Incorporated (DGX)?
The 5Y average interest coverage ratio for DGX stock is 8.84x.
What is the 10Y average interest coverage ratio for Quest Diagnostics Incorporated (DGX)?
The 10Y average interest coverage ratio for DGX stock is 7.06x.
What is the 15Y average interest coverage ratio for Quest Diagnostics Incorporated (DGX)?
The 15Y average interest coverage ratio for DGX stock is 6.84x.

DGX Interest Coverage Ratio History

DATEINTEREST COVERAGE RATIO
2026-03-316.33x
2025-12-315.84x
2025-09-305.59x
2025-06-306.35x
2025-03-314.81x
2024-12-315.01x
2024-09-305.69x
2024-06-307.55x
2024-03-316.12x
2023-12-315.80x
2023-09-308.34x
2023-06-308.92x
2023-03-318.24x
2022-12-313.75x
2022-09-3010.59x
2022-06-3010.21x
2022-03-3113.86x
2021-12-3114.11x
2021-09-3017.16x
2021-06-3014.03x
2021-03-3117.37x
2020-12-3119.88x
2020-09-3017.10x
2020-06-306.74x
2020-03-314.17x
2019-12-318.25x
2019-09-306.96x
2019-06-306.67x
2019-03-315.51x
2018-12-315.12x
2018-09-307.24x
2018-06-307.09x
2018-03-316.63x
2017-12-316.90x
2017-09-307.64x
2017-06-308.39x
2017-03-317.54x
2016-12-317.67x
2016-09-308.70x
2016-06-3012.41x
2016-03-317.14x
2015-12-316.64x
2015-09-3018.03x
2015-06-308.14x
2015-03-315.07x
2014-12-316.12x
2014-09-306.24x
2014-06-306.24x
2014-03-315.33x
2013-12-316.92x
2013-09-3017.24x
2013-06-307.24x
2013-03-315.69x
2012-12-316.63x
2012-09-307.41x
2012-06-307.99x
2012-03-317.08x
2011-12-317.43x
2011-09-307.31x
2011-06-306.80x
2011-03-316.97x
2010-12-317.77x
2010-09-309.23x
2010-06-309.99x
2010-03-318.29x
2009-12-319.43x
2009-09-3010.55x
2009-06-309.72x
2009-03-318.06x
2008-06-306.57x

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Secaucus, NJ
55,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James E. Davis